Is There a Benefit of Drug-Eluting Stents Rather than Bare Metal Stents in Large Coronary Artery Lesions? / 대한내과학회지
Korean Journal of Medicine
;
: 661-663, 2011.
Artículo
en Coreano
| WPRIM
| ID: wpr-201149
ABSTRACT
Drug-eluting stents (DES) are widely used rather than bare metal stents (BMS) in percutaneous coronary intervention (PCI) because DES have been shown to dramatically reduce restenosis and improve the rate of event free survival. Many clinical trials have been shown the advantages of DES over BMS in subset of small coronary artery diseases. There are, however, conflicting reports on the advantages of DES over BMS for larger coronary artery lesions. In this issue of the journal, Kim et al investigated the clinical outcomes between DES and BMS in large coronary artery diseases. In future, additional large, randomized, controlled, muticenter trials with new generation DES and intravascular ultrasound-guided PCI will be needed to define the clear role of DES on large coronary artery lesions.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Enfermedad de la Arteria Coronaria
/
Stents
/
Supervivencia sin Enfermedad
/
Vasos Coronarios
/
Stents Liberadores de Fármacos
/
Intervención Coronaria Percutánea
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS